Depression in older patients with neurologic illness: Causes, recognition, management

Cleveland Clinic Journal of Medicine

Volumn 72, Issue SUPPL.3, 2004, Pages

  Carson, Alan ^a   Margolin, Richard ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; DEPRESSION; HUMAN; NEUROLOGIC DISEASE; PSYCHOLOGICAL ASPECT; REVIEW;

AGED; DEPRESSIVE DISORDER; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84884559829     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.72.Suppl_3.S52     Document Type: Article

References (109)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA 1992; 268:1018-1024.
3. Gallo JJ, Rabins PV, Anthony JC. Sadness in older persons: 13- year follow-up of a community sample in Baltimore, Maryland. Psychol Med 1999; 29:341-350.
4. Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff A., eds. Diagnosis and Treatment of Depression in Late Life: Results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Press; 1994.
5. Katz IR, Parmelee P, Streim J. Depression in older patients in residential care: significance of dysphoria and dimensional assessment. Am J Geriatr Psychiatry 1995; 3:161-169.
6. House A. Depression after stroke. Br Med J (Clin Res Ed) 1987; 294:76-78.
7. Carson AJ, Ringbauer B, MacKenzie L, Warlow C, Sharpe M. Neurological disease, emotional disorder, and disability: they are related: a study of 300 consecutive new referrals to a neurology outpatient department. J Neurol Neurosurg Psychiatry 2000; 68:202-206.
8. Parikh RM, Robinson RG, Lipsey JR, Starkstein SE, Fedoroff JP, Price TR. The impact of poststroke depression on recovery of activities of daily living over a 2-year follow-up. Arch Neurol 1990; 47:785-789.
9. Pohjasvaara T, Leppävuori A, Siira I, Vataja R, Kaste M, Erkinjuntti T. Frequency and clinical determinants of poststroke depression. Stroke 1998; 29:2311-2317.
10. The Global Parkinson's Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002; 17:60-67.
11. Jalava M, Sillanpaa M. Concurrent illnesses in adults with childhood- onset epilepsy: a population-based 35-year follow-up study. Epilepsia 1996; 37:1155-1163.
12. Stefansson SB, Olafsson E, Hauser WA. Psychiatric morbidity in epilepsy: a case controlled study of adults receiving disability benefits. J Neurol Neurosurg Psychiatry 1998; 64:238-241.
13. Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology 2002; 58:S27-S39.
14. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Mood disorders and multiple sclerosis. Arch Neurol 1987; 44:376-378.
15. Chwastiak L, Ehde DW, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002; 159:1862-1868.
16. Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke 2000; 31:1588-1601.
17. Williams LS, Ghose SS, Swindle RW. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 2004; 161:1090-1095.
18. Carson AJ, Postma K, Stone J, Warlow C, Sharpe M. The outcome of depressive disorders in neurology patients: a prospective cohort study. J Neurol Neurosurg Psychiatry 2003; 74:893-896.
19. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984; 1(8372):297-300.
20. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of post-stroke depression with the selective reuptake inhibitor citalopram. Stroke 1994; 25:1099-1104.
21. Olin JT, Schneider LS, Katz IR, et al. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry 2002; 10:125-128.
22. Modrego PJ, Ferrández J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type. Arch Neurol 2004; 61:1290-1293.
23. Coffey CE, Wilkinson WE, Parashos IA, et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 1991; 42(pt 1):527-536.
24. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci 2003; 23:3295-3301.
25. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 1989; 29:164-168.
26. Petit-Taboué MC, Landeau B, Desson JF, Desgranges B, Baron JC. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage 1998; 7:176-184.
27. Meltzer CC, Smith G, DeKosky ST, et al. Serotonin in aging, latelife depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 1998; 18:407-430.
28. Tauscher J, Verhoeff NP, Christensen BK, et al. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C] WAY-100635 and PET. Neuropsychopharmacology 2001; 24:522-530.
29. Lee HB, Lyketsos CG. Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry 2003; 54:353-362.
30. Zweig RM, Ross CA, Hedreen JC, et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 1988; 24:233-242.
31. Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990; 47:209-214.
32. Rabins PV, Pearlson GD, Aylward E, Kumar AJ, Dowell K. Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry 1991; 148:617-620.
33. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93:3908-3913.
34. Krishnan KR, McDonald WM, Doraiswamy PM, et al. Neuroanatomical substrates of depression in the elderly. Eur Arch Psychiatry 1993; 154:497-500.
35. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501.
36. Kumar A, Bilker W, Jin Z, Udupa J. Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology 2000; 22:264-274.
37. Gordon WA, Hibbard MR. Poststroke depression: an examination of the literature. Arch Phys Med Rehabil 1997; 78:658-663.
38. Desmond DW, Remien RH, Moroney JT, Stern Y, Sano M, Williams JB. Ischemic stroke and depression. J Int Neuropsychol Soc 2003; 9:429-439.
39. Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature 1975; 255:332-334.
40. Carson AJ, MacHale S, Allen K, House A, Dennis M, Sharpe M. Depression after stroke is not associated with lesion location: a systematic review. Lancet 2000; 356:122-126.
41. Carota A, Staub F, Bogousslavsky J. Emotions, behaviours and mood changes in stroke. Curr Opin Neurol 2002; 15:57-69.
42. Kim JS, Choi-Kwon S. Poststroke depression and emotional incontinence: correlation with lesion location. Neurology 2000; 54:1805-1810.
43. Greenwald BS, Kramer-Ginsberg E, Krishnan RR, Ashtari M, Aupperle PM, Patel M. MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1996; 153:1212-1215.
44. Salloway S, Malloy P, Kohn R, et al. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996; 46:1567-1574.
45. Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997; 277:333-340.
46. Yesavage J. Geriatric depression scale. Mood scale (short form). Aging Clinical Research Center, Stanford University School of Medicine. Available at: www.stanford.edu/~yesavage/GDS.english. short.score.html. Accessed June 30, 2005.
47. Gainotti G, Azzoni A, Razzano C, et al. The Post-Stroke Depression Scale: a test specifically devised to investigate affective disorders of stroke patients. J Clin Exp Neuropsychol 1997; 19:340-356.
48. Gainotti G, Azzoni A, Marra C. Frequency phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry 1999; 175:163-167.
49. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984; 65:135-138.
50. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994; 21:9-14.
51. Brooks DJ, Doder M. Depression in Parkinson's disease. Curr Opin Neurol 2001; 14:465-470.
52. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361-370.
53. Alexopoulos GS. Late-life mood disorders. In: Sadavoy J, Jarvik LF, Grossberg GT, Meyers BS, eds. Comprehensive Textbook of Geriatric Psychiatry. 3rd ed. New York: WW Norton and Co; 2004:609-653.
54. Cantello R, Gilli, Riccio A, Bergamasco B. Mood changes associated with "end-of-dose" deterioration in Parkinson's disease: a controlled study. J Neurol Neurosurg Pscyhiatry 1986; 49:1182-1190.
55. Menza MA, Sage J, Marshall E, Cody R, Duvoisin R. Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord 1990; 5:148-151.
56. Keshavan MS, David AS, Narayanen HS, Satish P. "On-off" phenomena and manic-depressive mood shifts: case report. J Clin Psychiatry 1986; 47:93-94.
57. Neilley LK, Goodin DS, Goodkin DE, Hauser SL. Side effect profile of interferon beta-1b in multiple sclerosis: results of an openlabel trial. Neurology 1996; 46:552-554.
58. Patten SB, Metz LM. Interferon ß-1a and depression in relapsingremitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial. Mult Scler 2001; 7:243-248.
59. Zephir H, De Seze J, Stojkovic T, et al. Multiple sclerosis and depression: influence of interferon ß therapy. Mult Scler 2003; 9:284-288.
60. Feinstein A, O'Connor P, Feinstein K. Multiple sclerosis, interferon beta-1b and depression: a prospective investigation. J Neurol 2002; 249:815-820.
61. Bogousslavsky J, Cummings JL. Behaviour and Mood Disorders in Focal Brain Lesions. New York: Cambridge University Press; 2000.
62. Carota A, Rossetti AO, Karapanayiotides T, Bogousslavsky J. Catastrophic reaction in acute stoke: a reflex behavior in aphasic patients. Neurology 2001; 57:1902-1905.
63. Lazar RM, Marshall RS, Prell GD, Pile-Spellman J. The experience of Wernicke's aphasia. Neurology 2000; 55:1222-1224.
64. Starkstein SE, Berthier ML, Fedoroff P, Price TR, Robinson RG. Anosognosia and major depression in 2 patients with cerebrovascular lesions. Neurology 1990; 40:1380-1382.
65. Damasio AR. Emotion, Reason and the Human Brain. New York: GP Putnam Sons; 1994.
66. Ramasubbu R. Denial of illness and depression in stroke [letter]. Stroke 1994; 25:226-227.
67. Ross ED. Affective prosody and the aprosodias. In: Mesulam MM, ed. Principles of Behavioural and Cognitive Neurology. New York: Oxford University Press; 2000:316-331.
68. Fisher CM. Abulia. In: Bogousslavsky J, Caplan L, eds. Stroke Syndromes. Cambridge, UK: Cambridge University Press; 1995.
69. Starkstein SE, Fedoroff JP, Price TR, Leiguarda R, Robinson RG. Apathy following cerebrovascular lesions. Stroke 1993; 24:1625-1630.
70. Petersen RC, ed. Mild Cognitive Impairment: Aging to Alzheimer's Disease. New York: Oxford University Press; 2003.
71. McGuire MH, Rabins PV. Mood disorders. In: Coffee EC, Cummings JL, eds. Textbook of Geriatric Neuropsychiatry. Washington, DC: American Psychiatric Press; 1994:243-260.
72. Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry 1993; 150:1694-1699.
73. Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD. Provisional diagnostic criteria for depression of Alzheimer disease. Rationale and background. Am J Geriatr Psychiatry 2002; 10:129-141.
74. Carson AJ, Best S, Warlow C, Sharpe M. Suicidal ideation among outpatients at general neurology clinics: prospective study. BMJ 2000; 320:1311-1312.
75. McIntosh JL, Santos JF, Hubbard RW, Overholser JC. Elder Suicide: Research, Theory and Treatment. Washington, DC: American Psychological Association; 1994.
76. Barbui C, Hotopf M, Freemantle N, et al. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Cochrane Database Syst Rev 2000; 4:CD002791.
77. Donoghue J, Hylan TR. Antidepressant use in clinical practice: efficacy v. effectiveness. Br J Psychiatry Suppl 2001; 42:S9-S17.
78. Anderson IM, Tomeson BM. Treatment discontinuation with selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1995; 310:1433-1438.
79. Stone J, Durrance D, Wojcik W, Carson A, Sharpe M. What do medical outpatients attending a neurology clinic think about antidepressants? J Psychosom Res 2004; 56:293-295.
80. Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000; 157:351-359.
81. Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 2001; 71:258-261.
82. Chemerinski E, Robinson RG, Kosier JT. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 2001; 32:113-117.
83. Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000; 31:1829-1832.
84. Kneebone II, Dunmore E. Psychological management of poststroke depression. Br J Clin Psychol 2000; 39:53-65.
85. Lincoln NB, Flannaghan T. Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke 2003; 34:111-115.
86. Lincoln NB, Flannaghan T, Sutcliffe L, Rother L. Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil 1997; 11:114-122.
87. Feinstein A. Multiple sclerosis, depression, and suicide. BMJ 1997; 315:691-692.
88. Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990; 147:1493-1497.
89. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001; 56(suppl 5):S1-S88.
90. Ceravolo R, Nuti A, Piccinni A, et al. Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology 2000; 55:1216-1218.
91. Tesei S, Antonini A, Canesi M, Zecchinelli A, Mariani CB, Pezzoli G. Tolerability of paroxetine in Parkinson's disease: a prospective study. Mov Disord 2000; 15:986-989.
92. Chuinard G, Sultan S. A case of Parkinson's disease exacerbated by fluoxetine. Hum Psychopharmacol 1992; 7:63-66.
93. Jansen Steur ENH. Increase in Parkinson disability after fluoxetine medication. Neurology 1993; 43:211-213.
94. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychol 1996; 57:449-454.
95. Armin S, Andreas H, Hermann W, et al. Pramipexole, a dopamine agonist, in major depression: antidepressant effects and tolerability in an open-label study with multiple doses. Clin Neuropharmacol 1997; 20:S36-S45.
96. George MS, Wassermann EM, Post RM. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. J Neuropsychiatry Clin Neurosci 1996; 8:373-382.
97. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000; 47:246-249.
98. Reifler BV, Teri L, Raskind M, et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression [see comments]. Am J Psychiatry 1989; 146:45-49.
99. Lyketsos CG, DelCampo L, Steinberg M, et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry 2003; 60:737-746.
100. Kellner CH, Coffey CE, Greenberg RM. Electroconvulsive therapy. In: Sadavoy J, Jarvik LF, Grossberg GT, Meyers BS, eds. Comprehensive Textbook of Geriatric Psychiatry. New York: WW Norton and Company; 1994:845-901.
101. Sackheim HA. The use of electroconvulsive therapy in late-life depression. In: Salzman C, ed. Geriatric Psychopharmacology. 3rd ed. Baltimore: Williams and Wilkins; 1998:262-309.
102. Faber R, Trimble MR. Electroconvulsive therapy in Parkinson's disease and other movement disorders. Mov Disord 1991; 6:293-303.
103. Moellentine C, Rummans T, Ahlskog JE, et al. Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci 1998; 10:187-193.
104. Currier MB, Murray GB, Welch CC. Electroconvulsive therapy for post-stroke depressed geriatric patients. J Neuropsychiatry Clin Neurosci 1992; 4:140-144.
105. Coffey CE, Figiel GS, Djang WT, Saunders WB, Weiner RD. White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. J Neuropsychiatry Clin Neurosci 1989; 1:135-144.
106. Rao V, Lyketsos CG. The benefits and risks of ECT for patients with primary dementia who also suffer from depression [see comment]. Int J Geriatr Psychiatry 2000; 15:729-735.
107. Frazer CJ, Christensen H, Griffiths KM. Systematic review. Effectiveness of treatments for depression in older people. Med J Aust 2005; 182:627-632.
108. Niederehe GT. Psychosocial therapies with depressed older adults. In: Schneider LS, Reynolds CF 3rd, Lebowitz BD, Friedhoff AJ, eds. Diagnosis and Treatment of Depression in Late Life. Washington, DC: American Psychiatric Press; 1994:294-313.
109. Thompson LW, Coon DW, Gallagher-Thompson D, Sommer BR, Koin D. Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression. Am J Geriatr Psychiatry 2001; 9:225-240